INTRODUCTION

Ψ
Syphilis is the disease caused by Treponema pallidum subspecies (ssp.) pallidum. The term "serological activity" is considered in describing syphilis, to indicate the level of antibodies against Treponema pallidum ssp. pallidum in human blood. False positive serologic reactions are not rare because of cross-reactions with a concomitant disease or technical errors [1] [2] [3] . Since 1990, there has been an upward trend in the incidence of both acquired and congenital Ψ Correspondence at: Centre of Sexually Transmitted and Skin Diseases of Pauls Stradins Clinical University Hospital, Pērnavas ielā 70, LV-1009, Rīga, Latvia. Email: ozolins_dzintars@yahoo.com.sg syphilis in European countries, especially in Eastern Europe. Indeed, the incidence of syphilis has increased worldwide, and this phenomenon is clearly associated with sexual promiscuity and sexual tourism destinations 4 . The syphilis incidence in Latvia has been steadily decreasing in the past few years, but remains still high in comparison with more developed countries 5 . As a syphilitic infection can produce a variable range of symptoms in humans, laboratory tests are often required to definitively diagnose an infection 6 . Infection is initiated when Treponema pallidum ssp. pallidum enters tissues through dermal microabrasions or by penetration of intact mucosa, typically resulting in a single chancre at the site of inoculation. The primary chancre develops after an average incubation period of 3 weeks. The chancre usually heals spontaneously within 4-6 weeks, but it may still be discernible in about 15% of patients at the onset of secondary syphilis 7 . Treponema pallidum lacks lipopolysaccharide-the endotoxin, which is found in the outer membranes of many gram-negative bacteria that causes fever and inflammation. However, Treponema pallidum does produce a number of lipoproteins which may induce expression of inflammatory mediators via toll-like receptor 2 (TLR2) recognition 18 . Antibodies are usually produced either against Treponema pallidum ssp. pallidum or part of its component. Basic antigens, the determinants of Treponema pallidum ssp. pallidum are components of its triple layer outside wall and in separate cases the capsule-shaped mucopolysaccharides coupler. The most investigated protein antigens of Treponema pallidum ssp. pallidum, which contain a fraction are known to be common in bothpathogenic and saprophytic treponemas, and the antibodies are raised against these antigens. They also contain a fraction that is specific only to pathogenic treponemas. . A delay in dendritic cells maturation, resulting in slower inflammatory response, could allow the early dissemination of Treponema pallidum ssp. pallidum, which gives opportunity to the organism to penetrate organs and tissues before an active inflammatory response has been mounted by the host. Bacteriological investigation in a case of syphilis is not possible because Treponema pallidum ssp. pallidum does not grow on artificial media. Two basic methods are applied in the routine diagnosis of syphilismicroscopy (exudates from an ulcer, erosion or punctuate obtained from a lymph node) using dark visual field and serology. Microscopy shows Treponema pallidum ssp. pallidum in all lesions of early and late, but not in latent syphilis. In the human, infection with Treponema pallidum ssp. pallidum results in rapid production of two types of antibodies (nonspecific and specific) at the end of the incubation period or during the first week after onset of ulcus durum. The serological methods for the diagnosis of syphilis are classified as non-specific (non-treponemal) and specific (treponemal) tests. In non-specific tests, a nontreponemal antigen called cardiolipin, which is extracted from bovine heart muscle is used. These are mostly flocculation tests, where the formed "antigen + antibody" complexes comprise of flakes. In Latvia the non-specific tests, mostly Rapid Plasma Reagin (RPR) test are used. Non-treponemal tests are widely used for screening, although they are not reliable alone to confirm the diagnosis of syphilis. According to the European guidelines, the nontreponemal tests are used for the monitoring of serologic activity and the treatment of syphilis 9 . Antibodies to specific antigens of Treponema pallidum ssp. pallidum in blood serum and/or plasma are detected with the specific tests. Commercially available test systems use Nichol's strain TpN15, TpN17 and TpN47 recombinant antigens and synthetic peptide TmpA. Other recombinant antigens like Tp0453, Tp92 and Gpd can also be used 20 , although such test systems are not commercially available. In Latvia, TPHA (Treponema pallidum hemagglutination test) and ELISA (Enzyme-linked immunosorbent assay) are used recently. The above-mentioned specific treponemal tests are used to confirm the diagnosis of syphilis and as differential diagnostics
9, 21
. Historically, to confirm the cure of syphilis, in addition to non-treponemal tests, the reaction of complement binding (Wasserman) reaction and Treponema pallidum immobilisation reaction (TPIR) or Nelson test, both being specific tests, were used. Nowadays these tests are not used routinely, although the TPIR is applied in specialised laboratories in Latvia. The diagnostic value of non-specific antibodies is limited: firstly, in early primary disease, antilipoidal antibodies may not be developed and in late syphilis (late latent and tertiary), up to 30 % of individuals there may be lack of antilipoidal antibodies 20 and secondly, nontreponemal tests are highly sensitive in secondary syphilis, but in other forms their sensitivity is not sufficient ( Table 1) 10 . Therefore, it is essential to find out highly sensitive tests in monitoring the serological activity and the efficacy of treatment in cases of latent syphilis.
Studies of this type have several problems, the major one being lack of a "gold standard" for the direct detection of Treponema pallidum ssp. pallidum. Serological confirmation may be delayed, absent, or difficult to interpret the cases of potential reinfection or reactivation of disease 22 . This study was aimed to estimate and compare the sensitivity and specificity of RPR, TPHA and Syphilis ELISA IgG, IgM. A retrospective analysis of medical documentation was used as the reference.
METHODOLOGY
Study population
The retrospective study was conducted by analyzing the medical records of 18,799 patients (10,220 males and 8,579 females) of age ranges from 17 to 67 years (mean age 40. Results were identified as true positive and false negative in relation to the retrospective study of the participants' clinical records.
Techniques
The assay was performed strictly following manufacturer's instructions:
RPR:
This assay was performed in 15,829 patients.
The commercially available cardiolipin antigen produced by "Biokit" (Spain) was used 21 . The assay was performed according to manufacturer's instructions.
TPHA:
It was performed in 1,474 patients. The test system "Cellognost Syphilis H" produced by "Dade Behring" (Germany) was used. Absorbed serum was added to sheep red blood cells sensitised with Treponema pallidum (Nichols strain) sonicate in a microtiter tray. Agglutination of the red cells was produced by antibody containing serum 21 . Test was considered as negative, if the agglutination was not stated. Test was positive, if hemagglutination occured, that was expressed semi-quantitatively in the interval of 1+ till 4+. SYPHILIS ELISA IgG, IgM: It was performed in 1,496 patients. The testsystem "Enzygnost" produced by "Dade Behring" (Germany) was used. The test was performed by incubating test specimens in microplate well coated with p15, p17 and p47 Treponema pallidum recombinant antigens. The specific antibodies IgG and IgM presented in sample bound to the solid-phase antigens. Subsequently, the wells were washed to remove residual test sample and p15, p17 and p47 Treponema pallidum recombinant antigens conjugated with the enzyme peroxidase were added. The conjugate bound to the captured specific antibodies. After another washing to eliminate unbound material, a solution of enzyme substrate and chromogen was added. This solution developed blue colour if the sample contained anti-Treponema pallidum antibodies. The blue colour changed to yellow after blocking the reaction with sulphuric acid. The intensity of colour was proportional to the antiTreponema pallidum antibodies concentration in the sample 21 .
RESULTS
The sensitivity of TPHA and ELISA IgG, IgM was much higher i.e. 100.0 % as compared to the sensitivity of RPR (58.8 %). As far as specificity is concerned, it was found to highest by using ELISA IgG, IgM method (100%). The specificity of TPHA and RPR was 66.7% and 33.3 % respectively. The obtained results of sensitivity and specificity with RPR, TPHA and syphilis ELISA IgG, IgM methods are shown in Figure  3 . 
DISCUSSION
The sensitivity of non-treponemal tests to find out late latent syphilis patients in the population without clinical and epidemiological signs of syphilis is not high enough. Our result of sensitivity of RPR (58.8 %) agrees with the data of RPR (73%) presented in Table 1 10 . Non-treponemal tests used for screening have the advantage of being widely available, inexpensive, convenient to perform on large numbers of specimens, and necessary for determining the efficacy of treatment. Limitations of the nontreponemal serological tests include their lack of sensitivity in early dark-field-positive primary cases and in late syphilis due their possibility of a prozone reaction or false-positive results 10 . Therefore, RPR assay is not recommended for screening purposes to find out late latent syphilis cases due to its limitations and because of the availability of other more reliable syphilis screening tests. TPHA and ELISA IgG, IgM methods could be recommended for screening diagnostics because they possess high sensitivity and ELISA IgG, IgM is reasonably used to confirm the diagnosis due its highest specificity (100%). Limitations of the ELISAs are time and cost when small numbers of samples are to be processed
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. TPHS alone could not be used to confirm the diagnosis because of having low specificity (66.7%). Despite the dramatic advances in other biomedical fields, the tools for the management and control of syphilis have changed little in the past sixty years
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. New molecular tests for syphilis are unlikely to replace serology in the short term because they are fairly expensive and require sophisticated equipment 24 . Nevertheless, there are data concerning the importance of treating syphilis during pregnancy with penicillin, and the endorsement of the use of molecular techniques to identify Treponema pallidum subsp. pallidum in clinical samples to diagnose congenital early syphilis
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. Also, a one-step sandwich chemoluminescence immunoassay (CLIA) is reported as a screening test and as a confirmatory test for the diagnosis of syphilis 26 . The use of recombinant Treponema pallidum ssp. pallidum antigens TpN47 (Tp0574), TpN17, TpN15 (Tp0171), TmpA, TpN44. 
CONCLUSION
The sensitivity of non-treponemal tests for late latent syphilis patients is not high enough to monitor the treatment of syphilis. TPHA and ELISA IgG, IgM methods are useful for syphilis screening diagnostics because of having high sensitivity and ELISA IgG, IgM is recommended to confirm the diagnosis due to its highest specificity (100%).
